Our initial experiments revealed that HA treatment of MDA-MB-231 BC cells significantly increased CD44 expression at 24 h, which was accompanied by a parallel pattern of expression of its transcriptional target SOD2 at RNA levels. The gene discussed is SOD2; the disease is breast cancer.